179 related articles for article (PubMed ID: 22571802)
41. [The role of estrogen in the formation and development of abdominal aortic aneurysm: experiment with rats].
Wu XF; Zhang J; Xin SJ; Duan ZQ; Zhang G
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):471-4. PubMed ID: 17459227
[TBL] [Abstract][Full Text] [Related]
42. Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall.
Nagashima H; Aoka Y; Sakomura Y; Uto K; Sakuta A; Aomi S; Kurosawa H; Hagiwara N; Kawana M; Kasanuki H
J Vasc Surg; 2004 Feb; 39(2):447-53. PubMed ID: 14743151
[TBL] [Abstract][Full Text] [Related]
43. Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm.
Eugster T; Huber A; Obeid T; Schwegler I; Gürke L; Stierli P
Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):378-82. PubMed ID: 15749038
[TBL] [Abstract][Full Text] [Related]
44. Deficiency of MMP17/MT4-MMP proteolytic activity predisposes to aortic aneurysm in mice.
Martín-Alonso M; García-Redondo AB; Guo D; Camafeita E; Martínez F; Alfranca A; Méndez-Barbero N; Pollán Á; Sánchez-Camacho C; Denhardt DT; Seiki M; Vázquez J; Salaices M; Redondo JM; Milewicz D; Arroyo AG
Circ Res; 2015 Jul; 117(2):e13-26. PubMed ID: 25963716
[TBL] [Abstract][Full Text] [Related]
45. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation.
Eliason JL; Hannawa KK; Ailawadi G; Sinha I; Ford JW; Deogracias MP; Roelofs KJ; Woodrum DT; Ennis TL; Henke PK; Stanley JC; Thompson RW; Upchurch GR
Circulation; 2005 Jul; 112(2):232-40. PubMed ID: 16009808
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of interleukin-1β and interferon-γ in type I thoracic aortic dissections and ascending thoracic aortic aneurysms: possible correlation with matrix metalloproteinase-9 expression and apoptosis of aortic media cells.
Zhang L; Liao MF; Tian L; Zou SL; Lu QS; Bao JM; Pei YF; Jing ZP
Eur J Cardiothorac Surg; 2011 Jul; 40(1):17-22. PubMed ID: 21349736
[TBL] [Abstract][Full Text] [Related]
47. Clearance of matrix metalloproteinase-9 is dependent on low-density lipoprotein receptor-related protein-1 expression downregulated by microRNA-205 in human abdominal aortic aneurysm.
Chan CY; Chan YC; Cheuk BL; Cheng SW
J Vasc Surg; 2017 Feb; 65(2):509-520. PubMed ID: 26781079
[TBL] [Abstract][Full Text] [Related]
48. Biomarkers for abdominal aortic aneurysms from a sex perspective.
Villard C; Wågsäter D; Swedenborg J; Eriksson P; Hultgren R
Gend Med; 2012 Aug; 9(4):259-266.e2. PubMed ID: 22721599
[TBL] [Abstract][Full Text] [Related]
49. Matrix metalloproteinase expressions in arteriosclerotic aneurysmal disease.
Saito S; Zempo N; Yamashita A; Takenaka H; Fujioka K; Esato K
Vasc Endovascular Surg; 2002; 36(1):1-7. PubMed ID: 12704518
[TBL] [Abstract][Full Text] [Related]
50. Osteopontin expression and its possible functions in the aortic disorders and coronary artery disease.
Yuan SM; Wang J; Huang HR; Jing H
Rev Bras Cir Cardiovasc; 2011; 26(2):173-82. PubMed ID: 21894406
[TBL] [Abstract][Full Text] [Related]
51. Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall.
Crowther M; Goodall S; Jones JL; Bell PR; Thompson MM
Br J Surg; 2000 Oct; 87(10):1391-400. PubMed ID: 11044166
[TBL] [Abstract][Full Text] [Related]
52. Altered patterns of gene expression specific to thoracic aortic aneurysms: microarray analysis of surgically resected specimens.
Taketani T; Imai Y; Morota T; Maemura K; Morita H; Hayashi D; Yamazaki T; Nagai R; Takamoto S
Int Heart J; 2005 Mar; 46(2):265-77. PubMed ID: 15876810
[TBL] [Abstract][Full Text] [Related]
53. Phenotypic switching of vascular smooth muscle cells in animal model of rat thoracic aortic aneurysm.
Mao N; Gu T; Shi E; Zhang G; Yu L; Wang C
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):62-70. PubMed ID: 25829166
[TBL] [Abstract][Full Text] [Related]
54. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
[TBL] [Abstract][Full Text] [Related]
55. The nitric oxide donor DETA-NONOate decreases matrix metalloproteinase-9 expression and activity in rat aortic smooth muscle and abdominal aortic explants.
Sinha I; Hannawa KK; Ailawadi G; Woodrum DT; Ford JW; Henke PK; Stanley JC; Eagleton MJ; Upchurch GR
Ann Vasc Surg; 2006 Jan; 20(1):92-8. PubMed ID: 16378139
[TBL] [Abstract][Full Text] [Related]
56. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction.
Chew DK; Conte MS; Khalil RA
J Vasc Surg; 2004 Nov; 40(5):1001-10. PubMed ID: 15557917
[TBL] [Abstract][Full Text] [Related]
57. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Lorenzl S; Buerger K; Hampel H; Beal MF
Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
[TBL] [Abstract][Full Text] [Related]
58. Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms.
Ikonomidis JS; Gibson WC; Butler JE; McClister DM; Sweterlitsch SE; Thompson RP; Mukherjee R; Spinale FG
Circulation; 2004 Sep; 110(11 Suppl 1):II268-73. PubMed ID: 15364874
[TBL] [Abstract][Full Text] [Related]
59. Systemic dilation diathesis in patients with abdominal aortic aneurysms: a role for matrix metalloproteinase-9?
van Laake LW; Vainas T; Dammers R; Kitslaar PJ; Hoeks AP; Schurink GW
Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):371-7. PubMed ID: 15749037
[TBL] [Abstract][Full Text] [Related]
60. Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation.
Xiong W; Knispel R; Mactaggart J; Baxter BT
J Vasc Surg; 2006 Nov; 44(5):1061-6. PubMed ID: 17098543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
